|
|
||||||||
Nuclear Medicine Unit, Institute of Pathology, University of Siena, Siena, Italy
Correspondence: For correspondence or reprints contact: Angelo Vattimo, MD, Nuclear Medicine Unitof the University of Siena, Le Scotte Hospital, Viale Bracci, 53100 Siena, Italy.
ABSTRACT
Single injection dual-phase scintigraphy (early and late acquisitions) with 99mTc-MIBI was used to differentiate benign and malignant hot thyroid nodules. Methods: Thirteen euthyroid and two hyperthyroid patients displaying a hot thyroid nodule on the 99mTc scan due to an autonomously functioning thyroid nodule (AFTN) underwent early 1530 min) and late (34 hr) thyroid scintigraphy after the administration of 7401000 MBq 99mTc-MIBI. Visual scoring was done to assess nodular tracer uptake and retention. In addition, the nodular-to-thyroid (N/T) uptake ratio in the early and late image and the washout rates (WO) from the nodule and thyroidal tissue were measured. All patients underwent thyroid surgery. Results: Histopathology revealed a Hörthle cell tumor in three nodules, a benign adenoma with oxyphilic metaplasia in two nodules and a benign adenoma without oxyphilic cells in the remaining 10 nodules. The Hörthle cell tumor nodules displayed intense and persistent uptake of 99mTc-MIBI (N/T was 2.81 ± 0.52 and 5.53 ± 1.06 in early and late images, respectively; WO from the nodule was 12.33 ± 0.47, WO from the thyroidal tissue was 22.00 ± 3.56). The benign nodules showed intense uptake in the early image and intense uptake to absent retention in the late image (N/T was 2.94 ± 1.31 and 1.62 ± 0.50 in the early and late images, respectively; WO from the nodule was 20.25 ± 2.92, WO from the thyroidal tissue was 20.33 ± 2.92). Conclusion: Single injectiondual-phase 99mTc-MIBI scintigraphy of the thyroid with AFTN can identify nodules as a result of the activity of a Höthle cell tumor, since these tumors cause intense and persistent tracer uptake in contrast with a benign AFTN.
Key Words: thyroid scintigraphy technetium-99m-sestamibi ot nodules Hörthlecells tumor
This article has been cited by other articles:
![]() |
L.-F. de Geus-Oei, G. F.F.M. Pieters, J. J. Bonenkamp, A. H. Mudde, C. P. Bleeker-Rovers, F. H.M. Corstens, and W. J.G. Oyen 18F-FDG PET Reduces Unnecessary Hemithyroidectomies for Thyroid Nodules with Inconclusive Cytologic Results J. Nucl. Med., May 1, 2006; 47(5): 770 - 775. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. T. Jaskowiak, S. L. Sugg, J. Helke, M. R. Koka, and E. L. Kaplan Pitfalls of Intraoperative Quick Parathyroid Hormone Monitoring and Gamma Probe Localization in Surgery for Primary Hyperparathyroidism Arch Surg, June 1, 2002; 137(6): 659 - 669. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |